Robert Chatwani Sells 13,817 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the transaction, the insider directly owned 71,162 shares in the company, valued at $5,913,562.20. This trade represents a 16.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Robert Chatwani also recently made the following trade(s):

• On Monday, September 15th, Robert Chatwani sold 1,682 shares of Docusign stock. The stock was sold at an average price of $80.30, for a total transaction of $135,064.60.
• On Thursday, September 11th, Robert Chatwani sold 983 shares of Docusign stock. The stock was sold at an average price of $79.39, for a total transaction of $78,040.37.

Docusign Trading Down 0.5%

Shares of DOCU stock opened at $84.59 on Friday. Docusign Inc. has a 1 year low of $57.58 and a 1 year high of $107.86. The firm’s fifty day simple moving average is $76.39 and its 200 day simple moving average is $79.30. The firm has a market capitalization of $17.01 billion, a P/E ratio of 63.60, a price-to-earnings-growth ratio of 4.46 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last announced its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same quarter in the previous year, the firm posted $0.97 earnings per share. Docusign’s revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its board has initiated a share repurchase plan on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 6.6% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its stock is undervalued.

Institutional Trading of Docusign

Large investors have recently bought and sold shares of the stock. New Age Alpha Advisors LLC grew its position in Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company’s stock valued at $3,353,000 after acquiring an additional 36,273 shares during the period. Pinpoint Asset Management Ltd grew its position in Docusign by 54.3% in the first quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company’s stock valued at $4,639,000 after acquiring an additional 20,043 shares during the period. Concurrent Investment Advisors LLC bought a new stake in Docusign in the first quarter valued at $618,000. Gilman Hill Asset Management LLC grew its position in Docusign by 4.9% in the first quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company’s stock valued at $6,864,000 after acquiring an additional 3,904 shares during the period. Finally, Blair William & Co. IL grew its position in Docusign by 1.7% in the first quarter. Blair William & Co. IL now owns 387,542 shares of the company’s stock valued at $31,546,000 after acquiring an additional 6,460 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Evercore ISI boosted their price objective on Docusign from $90.00 to $92.00 and gave the company an “in-line” rating in a research report on Friday, September 5th. Morgan Stanley boosted their price objective on Docusign from $86.00 to $90.00 and gave the company an “equal weight” rating in a research report on Monday, September 8th. Bank of America boosted their price objective on Docusign from $85.00 to $102.00 and gave the company a “neutral” rating in a research report on Friday, September 5th. UBS Group set a $95.00 price objective on Docusign in a research report on Friday, September 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Docusign from $77.00 to $80.00 and gave the company a “neutral” rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.